Please login to the form below

Not currently logged in
Email:
Password:

Symdeko

This page shows the latest Symdeko news and features for those working in and with pharma, biotech and healthcare.

Vertex's two-drug cystic fibrosis treatment cleared in US

Vertex's two-drug cystic fibrosis treatment cleared in US

Vertex's two-drug cystic fibrosis treatment cleared in US. FDA approves Symdeko, which combines Kalydeco and tezacaftor. ... The new drug - called Symdeko - combines the active ingredient in Vertex’first CF therapy Kalydeco (ivacaftor) - first approved

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics